CJC-1295 (No DAC) is a shorter-acting analog of Growth Hormone-Releasing Hormone (GHRH), widely researched for its pulsatile stimulation of natural growth hormone release. Current studies are focused on its potential impact on:
Hormonal Rhythm Support
CJC-1295 (No DAC) is being studied for its ability to promote natural GH pulsatility without extended half-life effects.
Tissue Recovery and Repair
Researchers are exploring its influence on muscle regeneration, connective tissue healing, and cellular repair.
Age-Related Hormonal Decline
The compound is under investigation as a tool to study the decline of GH with age and its systemic impacts.
 
How It Works
CJC-1295 (No DAC) is a short-acting GHRH analog that binds to GHRH receptors on the anterior pituitary, stimulating the release of endogenous growth hormone in a physiological, pulse-like manner. Unlike the DAC (Drug Affinity Complex) version, this form has a shorter half-life (~30 minutes), allowing for more natural GH fluctuations. It is commonly studied alongside other peptides (e.g., Ipamorelin) for synergistic GH release without disrupting the body’s hormonal rhythm.
 
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations